**Core Concept**
The endemicity of hepatitis B is determined by the prevalence of the hepatitis B surface antigen (HBsAg) in a population. This measurement is crucial for understanding the risk of transmission and the need for vaccination and other control measures. HBsAg is a marker of active infection.

**Why the Correct Answer is Right**
The correct answer is the measurement of HBsAg prevalence, which is the proportion of individuals in a population who are infected with hepatitis B. This can be measured through serological tests, such as enzyme-linked immunosorbent assay (ELISA). HBsAg is a reliable indicator of active hepatitis B infection, and its prevalence is used to classify areas as high, intermediate, or low risk for hepatitis B transmission.

**Why Each Wrong Option is Incorrect**
**Option A:** Measuring HBsAg titer is not a suitable method for determining endemicity, as it does not provide information on the proportion of infected individuals in the population.
**Option B:** Measuring HBV DNA levels is not a direct measure of endemicity, although it can provide information on viral load and infectivity.
**Option C:** Measuring anti-HBs antibodies is a measure of immunity, not infection, and is not a suitable method for determining endemicity.

**Clinical Pearl / High-Yield Fact**
HBsAg prevalence is a critical indicator of hepatitis B endemicity and is used to guide public health policy and vaccination strategies. A high HBsAg prevalence (>8%) indicates a high-risk area, while a low prevalence (<1%) indicates a low-risk area. **Correct Answer: D. HBsAg prevalence.**